- Home
- Life Sciences
- Safety
- Pharmacovigilance Systems Strategy
Pharmacovigilance Systems Strategy
It is important for Life Sciences organizations to strategize the Pharmacovigilance system investments in alignment with their changing business needs. This will help them to differentiate themselves effectively to gain competitive advantage, and to achieve superior business performance.
Why PV Systems Strategy?
- Aligning IT initiative with business goals
- Investing in pharmacovigilance systems which conform to regulatory requirements
- Cultivating the IT/business partnership
- Improving IT operations/systems performance
How Can TAKE Solutions Help?
TAKE with its strong domain expertise understands diverse Pharmacovigilance systems and processes, and has deep understanding of industry requirements – to provide business needs assessment services, process design services, systems configuration and development services. TAKE is committed to deliver system strategy services foreseeing business clarity and impact.
Services offered include:
- As is system and process understanding - Pharmacovigilance function
- Pharmacovigilance IT strategy and roadmap
- PV Systems integration advisory services
- PV Technology best practices
Products/Services
- Signal management system
- Risk mitigation tracking system
Additional Offerings
-
Commercialization
A singular point of view.
-
Analytics & Business Intelligence
Comprehensive Life Sciences analytics through integrated data
Next Steps
-
Request for Info
-
Request for Demo
-
Schedule a Meeting
Worldwide Life Science Drug Safety Services Report 2013 Vendor Assessment Worldwide Life Sciences R&D IT Outsourcing Report 2011 Vendor Assessment.

-
TAKE’s SafetyReady™ is a solution based on a proprietary framework for the rapid deployment....
-
Pharmacovigilance, the monitoring of the quality, safety and efficacy of marketed medicines...

-
Being a company with vision for the future, we had sensed well in advance that the future belongs...
-
ARGUS Safety Migrate & Upgrade project for a Medical Device business unit of a large…

-
CDER - Center for Drug Evaluation and Research - Human Drugs

-
- Drug Safety Directions
Pharmaceutical and biotech companies are going through rapid change with significant pressures on cost management,..



